Atossa Genetics Current Ratio 2012-2018 | ATOS
Atossa Genetics current ratio from 2012 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Atossa Genetics Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2018-12-31 | $0.01B | $0.00B | 3.96 |
| 2018-09-30 | $0.01B | $0.00B | 3.92 |
| 2018-06-30 | $0.02B | $0.00B | 5.45 |
| 2018-03-31 | $0.01B | $0.00B | 7.96 |
| 2017-12-31 | $0.01B | $0.00B | 6.45 |
| 2017-09-30 | $0.00B | $0.00B | 2.75 |
| 2017-06-30 | $0.00B | $0.00B | 2.09 |
| 2017-03-31 | $0.00B | $0.00B | 1.96 |
| 2016-12-31 | $0.00B | $0.00B | 3.11 |
| 2016-09-30 | $0.01B | $0.00B | 5.28 |
| 2016-06-30 | $0.00B | $0.00B | 1.66 |
| 2016-03-31 | $0.00B | $0.00B | 2.55 |
| 2015-12-31 | $0.00B | $0.00B | 1.72 |
| 2015-09-30 | $0.01B | $0.00B | 2.90 |
| 2015-06-30 | $0.01B | $0.00B | 4.03 |
| 2015-03-31 | $0.01B | $0.00B | 3.26 |
| 2014-12-31 | $0.01B | $0.00B | 4.13 |
| 2014-09-30 | $0.01B | $0.00B | 7.61 |
| 2014-06-30 | $0.02B | $0.00B | 9.39 |
| 2014-03-31 | $0.02B | $0.00B | 16.36 |
| 2013-12-31 | $0.01B | $0.00B | 4.82 |
| 2013-09-30 | $0.01B | $0.00B | 4.43 |
| 2013-06-30 | $0.01B | $0.00B | 3.02 |
| 2013-03-31 | $0.00B | $0.00B | 2.15 |
| 2012-12-31 | $0.00B | $0.00B | 1.21 |
| 2012-09-30 | $0.00B | $0.00B | 0.39 |
| 2012-06-30 | $0.00B | $0.00B | 0.00 |
| 2012-03-31 | $0.00B | $0.00B | 0.00 |
| 2011-12-31 | $0.00B | $0.00B | 0.00 |
| 2011-09-30 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.032B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $104.363B | 22.88 |
| Intuitive Surgical (ISRG) | United States | $58.664B | 54.06 |
| Edwards Lifesciences (EW) | United States | $36.977B | 37.03 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $24.585B | 16.83 |
| IDEXX Laboratories (IDXX) | United States | $19.324B | 52.60 |
| Hologic (HOLX) | United States | $13.031B | 19.70 |
| Teleflex (TFX) | United States | $12.848B | 28.14 |
| ABIOMED (ABMD) | United States | $12.211B | 80.60 |
| Varian Medical Systems (VAR) | United States | $12.098B | 30.92 |
| DexCom (DXCM) | United States | $10.817B | 409.72 |
| STERIS (STE) | United Kingdom | $10.794B | 27.74 |
| Masimo (MASI) | United States | $6.762B | 41.98 |
| Penumbra (PEN) | United States | $4.621B | 261.47 |
| Globus Medical (GMED) | United States | $4.518B | 27.42 |
| Integra LifeSciences Holdings (IART) | United States | $4.381B | 20.62 |
| Wright Medical Group (WMGI) | Netherlands | $3.656B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $3.471B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.338B | 20.57 |
| Cantel Medical (CMD) | United States | $2.780B | 27.65 |
| Glaukos (GKOS) | United States | $2.585B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.241B | 18.22 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.994B | 21.66 |
| Nevro (NVRO) | United States | $1.863B | 0.00 |
| Inogen (INGN) | United States | $1.829B | 36.26 |
| OPKO Health (OPK) | United States | $1.436B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $1.102B | 0.00 |
| SILK RD MEDICAL (SILK) | United States | $1.091B | 0.00 |
| CryoLife (CRY) | United States | $1.074B | 115.76 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.046B | 28.42 |
| Accelerate Diagnostics (AXDX) | United States | $1.029B | 0.00 |
| Luminex (LMNX) | United States | $1.000B | 45.37 |
| Veracyte (VCYT) | United States | $0.960B | 0.00 |
| Shockwave Medical (SWAV) | United States | $0.928B | 0.00 |
| Fluidigm (FLDM) | United States | $0.927B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.922B | 175.00 |
| Intersect ENT (XENT) | United States | $0.917B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.903B | 36.95 |
| Natus Medical (BABY) | United States | $0.837B | 17.36 |
| AxoGen (AXGN) | United States | $0.827B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.768B | 26.81 |
| ViewRay (VRAY) | United States | $0.679B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.559B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.514B | 0.00 |
| TransEnterix (TRXC) | United States | $0.436B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.425B | 44.39 |
| Corindus Vascular Robotics (CVRS) | United States | $0.419B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.405B | 0.00 |
| Si-Bone (SIBN) | United States | $0.397B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.375B | 46.36 |
| Accuray (ARAY) | United States | $0.373B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.350B | 0.00 |
| IRadimed (IRMD) | United States | $0.308B | 65.16 |
| Neuronetics (STIM) | United States | $0.288B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.268B | 0.00 |
| Sientra (SIEN) | United States | $0.252B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.208B | 48.17 |
| SOLITON INC (SOLY) | $0.180B | 0.00 | |
| Nuvectra (NVTR) | United States | $0.171B | 0.00 |
| ConforMIS (CFMS) | United States | $0.161B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.152B | 0.00 |
| EDAP TMS (EDAP) | France | $0.142B | 489.00 |
| Alphatec Holdings (ATEC) | United States | $0.137B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.133B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.116B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.110B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.103B | 0.00 |
| Vermillion (VRML) | United States | $0.100B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.076B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.072B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.065B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.060B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.057B | 0.00 |
| Electromed (ELMD) | United States | $0.047B | 24.61 |
| Xtant Medical Holdings (XTNT) | United States | $0.038B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.034B | 0.00 |
| Neovasc (NVCN) | Canada | $0.032B | 0.00 |
| Avinger (AVGR) | United States | $0.032B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.027B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.026B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.024B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.022B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.020B | 63.67 |
| American Shared Hospital Services (AMS) | United States | $0.016B | 15.11 |
| Dynatronics (DYNT) | United States | $0.016B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.014B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.012B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.010B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.010B | 0.00 |
| Micron Solutions (MICR) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.006B | 0.00 |
| InspireMD (NSPR) | Israel | $0.006B | 0.00 |
| Presbia (LENS) | Ireland | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.002B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
| ALCON INC (ALC) | $0.000B | 0.00 |
